|
1
|
Chow KH, Factor RE and Ullman KS: The nuclear envelope environment and its cancer connections. Nat Rev Cancer. 12:196–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fischer EG: Nuclear morphology and the biology of cancer cells. Acta Cytol. 64:511–519. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burla R, La Torre M, Maccaroni K, Verni F, Giunta S and Saggio I: Interplay of the nuclear envelope with chromatin in physiology and pathology. Nucleus. 11:205–218. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG and Lee RT: Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem. 281:25768–25780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koch AJ and Holaska JM: Emerin in health and disease. Semin Cell Dev Biol. 29:95–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lammerding J, Hsiao J, Schulze PC, Kozlov S, Stewart CL and Lee RT: Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol. 170:781–791. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zink D, Fischer AH and Nickerson JA: Nuclear structure in cancer cells. Nat Rev Cancer. 4:677–687. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Broers JL, Raymond Y, Rot MK, Kuijpers H, Wagenaar SS and Ramaekers FC: Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol. 143:211–220. 1993.PubMed/NCBI
|
|
9
|
Machida H, Matsuo K, Yamagami W, Ebina Y, Kobayashi Y, Tabata T, Kanauchi M, Nagase S, Enomoto T and Mikami M: Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. Gynecol Oncol. 153:589–596. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM and Doherty JA: Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 111:60–68. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soslow RA: Histologic subtypes of ovarian carcinoma: An overview. Int J Gynecol Pathol. 27:161–174. 2008.PubMed/NCBI
|
|
12
|
Capo-chichi CD, Cai KQ, Simpkins F, Ganjei-Azar P, Godwin AK and Xu XX: Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med. 9:282011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Capo-chichi CD, Cai KQ, Testa JR, Godwin AK and Xu XX: Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol Cell Biol. 29:4766–4777. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong G, Chen P, Li L, Tan H, Zhou J, Zhou Y, Yang X and Wu X: Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis. Pathol Res Pract. 211:175–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Denny L: Ovarian fallopian tube, and primary peritoneal carcinoma. TNM Classification of Malignant Tumours. Brierley J, Gospodarowicz M and Wittekinnd C: Wiley Blackwell; Chichester: pp. 179–184. 2017
|
|
16
|
Varga VS, Ficsor L, Kamarás V, Jónás V, Virág T, Tulassay Z and Molnár B: Automated multichannel fluorescent whole slide imaging and its application for cytometry. Cytometry A. 75:1020–1030. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guilford J: Correlation. In: Fundamental Statistics in Psychology and Education. Morgan C: McGraw-Hill Book Company; New York, NY: pp. 152–173. 1950
|
|
18
|
Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, et al AOCS Group, : Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: An Ovarian Tumor Tissue Analysis consortium study. J Pathol Clin Res. 4:250–261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Köbel M, Kalloger SE, Huntsman DG, Santos JL, Swenerton KD, Seidman JD, Gilks CB; Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency, ; Vancouver BC: Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol. 29:203–211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kyo S, Ishikawa N, Nakamura K and Nakayama K: The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies. Cancer Med. 9:421–431. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Soslow RA, Brenton JD, Davidson B, Folkins AK, Kong CS, Malpica A, Soerjomataram I and Vang R: High-grade serous carcinoma of the ovary. Female genital tumours, WHO classification of tumours. Cheung AN, Ellenson LH and Gilks CB: International Agency for Research on Cancer; Lyon: pp. 45–47. 2019
|
|
22
|
Seidman JD, Ronnett BM, Shih IM, Cho KR and Kurman RJ: Epithelial tumors of the ovary. Blausteins's pathology of the female genital tract. Kurman RJ, Ellenson LH and Ronnett BM: Springer; Berlin: pp. 841–966. 2019, View Article : Google Scholar
|
|
23
|
Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM and Silva EG: Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 28:496–504. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vang R, Shih IeM and Kurman RJ: Ovarian low-grade and high-grade serous carcinoma: Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 16:267–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramalingam P: Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer. Oncology (Williston Park). 30:166–176. 2016.PubMed/NCBI
|
|
26
|
Kobel M, Hunstman DG, Lim D, McCluggage WG, Rabban JT and Shih I: Endometrioid carcinoma of the ovary. Female Genital Tumours, WHO Classification of Tumours. Cheung AN, Ellenson LH and Gilks CB: International Agency for Research on Cancer; Lyon: pp. 58–61. 2019
|
|
27
|
Kobel M, Bennett JA, Cheung AN, DeLair DF, Kiyokawa T and Shih I: Clear cell carcinoma of the ovary. Female Genital Tumours, WHO Classification of Tumours. Cheung AN, Ellenson LH and Gilks CB: International Agency for Research on Cancer; Lyon: pp. 65–67. 2019
|
|
28
|
Zeimet AG, Fiegl H, Goebel G, Kopp F, Allasia C, Reimer D, Steppan I, Mueller-Holzner E, Ehrlich M and Marth C: DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer. Gynecol Oncol. 121:24–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rodríguez IM and Prat J: Mucinous tumors of the ovary: A clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 26:139–152. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Capo-chichi CD, Cai KQ, Smedberg J, Ganjei-Azar P, Godwin AK and Xu XX: Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chin J Cancer. 30:415–425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim JK, Louhghalam A, Lee G, Schafer BW, Wirtz D and Kim DH: Nuclear lamin A/C harnesses the perinuclear apical actin cables to protect nuclear morphology. Nat Commun. 8:21232017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smith ER, Meng Y, Moore R, Tse JD, Xu AG and Xu XX: Nuclear envelope structural proteins facilitate nuclear shape changes accompanying embryonic differentiation and fidelity of gene expression. BMC Cell Biol. 18:82017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jevtić P, Edens LJ, Li X, Nguyen T, Chen P and Levy DL: Concentration-dependent effects of nuclear lamins on nuclear size in Xenopus and mammalian cells. J Biol Chem. 290:27557–27571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liddane AG, McNamara CA, Campbell MC, Mercier I and Holaska JM: Defects in emerin-nucleoskeleton binding disrupt nuclear structure and promote breast cancer cell motility and metastasis. Mol Cancer Res. 19:1196–1207. 2021. View Article : Google Scholar : PubMed/NCBI
|
